Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
British Journal of Haematology
|
February 25, 2017
Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry
Daniel Molin, Johan Linderoth, Björn E Wahlin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study
Johan Linderoth, Mats Jerkeman, Eva Cavallin-Ståhl, et al.
American Journal of Clinical Pathology
|
March 18, 2008
A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus
Mats Ehinger, Johan Linderoth, Birger Christensson, et al.
Experimental Cell Research
|
February 18, 2011
Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines
Malin Ageberg, Karin Rydström, Ola Lindén, et al.
European Journal of Haematology
|
July 20, 2007
Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma
Johan Linderoth, Mats Ehinger, Måns Akerman, et al.
Leukemia & Lymphoma
|
February 17, 2012
Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma
Karin Rydström, Patrick Joost, Mats Ehinger, et al.
Leukemia & Lymphoma
|
July 3, 2010
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Karin Rydström, Johan Linderoth, Heidi Nyman, et al.
Leukemia & Lymphoma
|
July 1, 2016
Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker
Muhammad Sharif Hasni, Mattias Berglund, Konstantin Yakimchuk, et al.
American Journal of Hematology
|
October 22, 2009
Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells
Ulrika Andréasson, Michael Dictor, Mats Jerkeman, et al.
Leukemia & Lymphoma
|
September 6, 2007
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma
Johan Linderoth, Mats Ehinger, Mats Jerkeman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
British Journal of Haematology
|
February 25, 2017
Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry
Daniel Molin, Johan Linderoth, Björn E Wahlin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study
Johan Linderoth, Mats Jerkeman, Eva Cavallin-Ståhl, et al.
American Journal of Clinical Pathology
|
March 18, 2008
A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus
Mats Ehinger, Johan Linderoth, Birger Christensson, et al.
Experimental Cell Research
|
February 18, 2011
Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines
Malin Ageberg, Karin Rydström, Ola Lindén, et al.
European Journal of Haematology
|
July 20, 2007
Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma
Johan Linderoth, Mats Ehinger, Måns Akerman, et al.
Leukemia & Lymphoma
|
February 17, 2012
Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma
Karin Rydström, Patrick Joost, Mats Ehinger, et al.
Leukemia & Lymphoma
|
July 3, 2010
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Karin Rydström, Johan Linderoth, Heidi Nyman, et al.
Leukemia & Lymphoma
|
July 1, 2016
Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker
Muhammad Sharif Hasni, Mattias Berglund, Konstantin Yakimchuk, et al.
American Journal of Hematology
|
October 22, 2009
Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells
Ulrika Andréasson, Michael Dictor, Mats Jerkeman, et al.
Leukemia & Lymphoma
|
September 6, 2007
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma
Johan Linderoth, Mats Ehinger, Mats Jerkeman, et al.
Page
of 2